{"id":35576,"date":"2025-11-06T17:44:56","date_gmt":"2025-11-06T22:44:56","guid":{"rendered":"https:\/\/joinastudy.ca\/?p=35576"},"modified":"2025-12-09T12:49:53","modified_gmt":"2025-12-09T17:49:53","slug":"glp-1-agonists-making-the-informed-choice","status":"publish","type":"post","link":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/","title":{"rendered":"GLP-1 Agonists: Making the Informed Choice"},"content":{"rendered":"

Curious about the science behind today\u2019s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists<\/strong> will break down everything you need to know \u2014 from how these drugs work, to their real-world results, side effects, and what\u2019s coming next in the pipeline.<\/p>\n

Today, we’re covering how someone might choose between GLP-1 molecules, using a goal-based approach. We’ll also go over typical dosing, and risks to watch out for when starting on this class of drugs for the first time.<\/p>\n

Below are some factors that influence which GLP-1 agonist might be the best choice depending on the situation and goals of the person considering their use:<\/p>\n

Primary Goal<\/b><\/h4>\n

If the main goal is blood sugar \/ HbA1c reduction<\/i> (e.g. in T2DM), many of the drugs listed above are viable.<\/p>\n

If weight loss \/ obesity is a major goal, drugs with obesity indications like Wegovy<\/a>, Zepbound<\/a>, or Saxenda<\/a>\u2014or higher doses of semaglutide\/liraglutide\u2014may be preferable.<\/p>\n

Cardiovascular & Renal Benefits<\/b><\/h4>\n

Some GLP-1s have shown strong evidence of reducing cardiovascular events (myocardial infarction, stroke) in people with T2DM + cardiovascular disease (see liraglutide<\/a>, semaglutide injectable<\/a>, dulaglutide<\/a>).\u00a0Also, kidney-protective effects have been demonstrated by many GLP-1 class molecules (overview:
\nCKD information<\/a>).<\/p>\n

Convenience & Route of Administration<\/b><\/h4>\n

Route of administration depends heavily on personal preference. GLP-1s can be taken via weekly injections, daily injections, or via oral formulations.<\/p>\n

Some people prefer fewer injections; others may prefer daily for more \u201cgranular\u201d control or dose titration.<\/p>\n

Oral semaglutide (Rybelsus<\/a>) offers a non-injection route but requires special timing due to bioavailability (empty stomach, etc.).<\/p>\n

Side Effect Profiles & Tolerability<\/b><\/h4>\n

Gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) are common, especially when initiating or increasing dose.<\/p>\n

There is some risk of pancreatitis (rare), gallbladder disease, and possible effects on thyroid C-cells (in animal studies). FDA GLP-1 safety summary: FDA GLP-1 Safety Communication<\/a>.<\/p>\n

The speed of dose escalation matters for tolerability.<\/p>\n

Cost, Insurance Coverage & Access<\/b><\/h4>\n

Due to demand, manufacturing supply and recency of discovery, these drugs tend to be expensive. Insurance may only cover certain brand-names or only if criteria are met (BMI thresholds, comorbidities, etc.).<\/p>\n

In Canada, Health Canada approvals exist, but reimbursement \/ public formulary status varies. (Health Canada GLP-1 listing: Drug Product Database<\/a>.)<\/p>\n

Supply issues have been present but are stabilizing in many regions.<\/p>\n

Patient Characteristics \/ Comorbidities<\/b><\/h4>\n

Kidney or liver disease, history of pancreatitis, risk of medullary thyroid carcinoma, pregnancy, may all affect safety on a case-by-case basis.<\/p>\n

Age could also affect which drug may be right for you (pediatric\/adolescent approvals differ).<\/p>\n

Typical Dosing & Titration<\/b><\/h3>\n

People prescribed GLP-1s typically start at a lower \u201cstarter dose\u201d to improve tolerability (especially GI side effects). The dose is then gradually increased (weekly or after a few weeks) until reaching a maintenance dose that balances efficacy & side effects.<\/p>\n

As an example, semaglutide injectable for diabetes (Ozempic<\/a>) might begin low, then increase in steps to full dose; obesity doses are higher.<\/p>\n

Oral semaglutide (Rybelsus<\/a>) has special guidelines: it is usually taken with a small amount of water after an overnight fast; wait before eating or taking other medications.<\/p>\n

Risks, Side Effects & Monitoring<\/b><\/h3>\n

Some common side effects may include<\/b> nausea, vomiting, diarrhea or constipation; decreased appetite; possibly mild hypoglycemia when used with other glucose-lowering drugs.<\/p>\n

Some less common but more serious risks are<\/b> pancreatitis; gallbladder disease; dehydration; kidney effects (if volume depletion); possible risk to pancreatic islets; possible thyroid risk (in animal studies).<\/p>\n

You may be at higher personal risk of serious side effects if<\/b> you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2; have severe GI disease; are pregnant; or have certain pancreatitis risks.<\/p>\n

 <\/p>\n

In Part 3<\/strong>, we’ll be looking at what new GLP-1 molecules are coming down the development pipeline, and what’s next for this class of \u00ab\u00a0miracle drugs.\u00a0\u00bb It\u2019s releasing exclusively on our blog November 11th, so make sure to add us to your bookmarks to stay up to date!:
\nhttps:\/\/joinastudy.ca\/canadian-health-blog\/<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

Sources<\/span><\/b>\u00a0<\/span><\/p>\n

https:\/\/my.clevelandclinic.org\/health\/treatments\/13901-glp-1-agonists<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/health-product-infowatch\/december-2024.html<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/26371721\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.endocrinologyadvisor.com\/ddi\/glp-1-agonists\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/hopkinsdiabetesinfo.org\/medications-for-type-2-diabetes-glp-1-agonists\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551568\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.ncbi.nlm.nih.gov\/books\/n\/rc72848269830370\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/drug-shortages\/information-consumers\/supply-notices\/ozempic.html<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.practicenursing.com\/content\/clinical\/glp-1-receptor-agonists-and-their-role-in-managing-type-2-diabetes<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.drugs.com\/medical-answers\/glp-1-drug-best-weight-loss-3579236\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.primetherapeutics.com\/en\/glp-1-pipeline-update-november-2024<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/drug-shortages\/information-consumers\/supply-notices\/ozempic.html\/1000.html<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.avalanchept.com\/post\/comprehensive-list-of-fda-approved-glp-1-receptor-agonists-as-of-mid-2025<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.powerpak.com\/course\/content\/118150<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.powerpak.com\/course\/content\/114864<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.primetherapeutics.com\/glp-1-pipeline-update-february-2025<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/primetherapeutics.com\/glp-1-pipeline-update-may-2025<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/primetherapeutics.com\/glp-1-pipeline-november-2024<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.primetherapeutics.com\/glp-1-pipeline-update-november-2024<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/www.beckershospitalreview.com\/glp-1s\/glp-1-drug-approvals-a-breakdown.html<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/acgng.org\/most-popular-glp-1-medications\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n

https:\/\/sanemd.com\/glp-1-medications\/glp-1-medications-list-benefits-uses-side-effects\/<\/span><\/b><\/a>\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Curious about the science behind today\u2019s most talked-about diabetes and weight-management treatments? Our new, four-part blog series on GLP-1 Agonists will break down everything you need to know \u2014 from how these drugs work, to their real-world results, side effects, and what\u2019s coming next in the pipeline. Today, we’re covering how someone might choose between<\/p>\n","protected":false},"author":964,"featured_media":29913,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[603,605,489,513,515],"tags":[],"class_list":["post-35576","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-obesity-weight-loss","category-diabetes","category-industry-news","category-health-and-wellness","category-health-guides","category-603","category-605","category-489","category-513","category-515","description-off"],"acf":[],"yoast_head":"\nGLP-1 and Diabetes: A Comprehensive Guide - JoinAStudy.ca<\/title>\n<meta name=\"description\" content=\"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Agonists: Making the Informed Choice\" \/>\n<meta property=\"og:description\" content=\"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/\" \/>\n<meta property=\"og:site_name\" content=\"JoinAStudy.ca\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/joinastudy.ca\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-06T22:44:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-09T17:49:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1478\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"JoinAStudy Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:site\" content=\"@JoinAStudy_ca\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"JoinAStudy Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/\"},\"author\":{\"name\":\"JoinAStudy Team\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\"},\"headline\":\"GLP-1 Agonists: Making the Informed Choice\",\"datePublished\":\"2025-11-06T22:44:56+00:00\",\"dateModified\":\"2025-12-09T17:49:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/\"},\"wordCount\":850,\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg\",\"articleSection\":[\"Obesity & Weight Loss\",\"Diabetes\",\"Industry News\",\"Health and Wellness\",\"Health Guides\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/\",\"name\":\"GLP-1 and Diabetes: A Comprehensive Guide - JoinAStudy.ca\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg\",\"datePublished\":\"2025-11-06T22:44:56+00:00\",\"dateModified\":\"2025-12-09T17:49:53+00:00\",\"description\":\"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#primaryimage\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg\",\"width\":2560,\"height\":1478,\"caption\":\"A scientist holding bacterial samples for their antimicrobial susceptibility. Original image sourced from US Government department: Public Health Image Library, Centers for Disease Control and Prevention. Under US law this image is copyright free, please credit the government department whenever you can”.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/glp-1-agonists-making-the-informed-choice\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Agonists: Making the Informed Choice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"name\":\"JoinAStudy.ca\",\"description\":\"JoinAStudy.ca - Help create a healthier future\",\"publisher\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#organization\",\"name\":\"JoinAStudy.ca\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"contentUrl\":\"https:\\\/\\\/joinastudy.ca\\\/wp-content\\\/uploads\\\/JoinaStudy-Logo-Mobile-e1520526932796.png\",\"width\":118,\"height\":65,\"caption\":\"JoinAStudy.ca\"},\"image\":{\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/joinastudy.ca\",\"https:\\\/\\\/x.com\\\/JoinAStudy_ca\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC_ed0XmzH5ImSNOEJcdXKqg\"],\"publishingPrinciples\":\"https:\\\/\\\/joinastudy.ca\\\/why-join-a-study\\\/\",\"ownershipFundingInfo\":\"https:\\\/\\\/joinastudy.ca\\\/information-disclaimer\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/#\\\/schema\\\/person\\\/da824a10716e724d72676ec94d865d71\",\"name\":\"JoinAStudy Team\",\"url\":\"https:\\\/\\\/joinastudy.ca\\\/fr\\\/author\\\/grant\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GLP-1 and Diabetes: A Comprehensive Guide - JoinAStudy.ca","description":"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/","og_locale":"fr_FR","og_type":"article","og_title":"GLP-1 Agonists: Making the Informed Choice","og_description":"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.","og_url":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/","og_site_name":"JoinAStudy.ca","article_publisher":"https:\/\/www.facebook.com\/joinastudy.ca","article_published_time":"2025-11-06T22:44:56+00:00","article_modified_time":"2025-12-09T17:49:53+00:00","og_image":[{"width":2560,"height":1478,"url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg","type":"image\/jpeg"}],"author":"JoinAStudy Team","twitter_card":"summary_large_image","twitter_creator":"@JoinAStudy_ca","twitter_site":"@JoinAStudy_ca","twitter_misc":{"\u00c9crit par":"JoinAStudy Team","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#article","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/"},"author":{"name":"JoinAStudy Team","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71"},"headline":"GLP-1 Agonists: Making the Informed Choice","datePublished":"2025-11-06T22:44:56+00:00","dateModified":"2025-12-09T17:49:53+00:00","mainEntityOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/"},"wordCount":850,"publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg","articleSection":["Obesity & Weight Loss","Diabetes","Industry News","Health and Wellness","Health Guides"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/","url":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/","name":"GLP-1 and Diabetes: A Comprehensive Guide - JoinAStudy.ca","isPartOf":{"@id":"https:\/\/joinastudy.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#primaryimage"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#primaryimage"},"thumbnailUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg","datePublished":"2025-11-06T22:44:56+00:00","dateModified":"2025-12-09T17:49:53+00:00","description":"Gain insights about GLP-1 agonists. Find out their benefits, risks, and how to choose the right one for your needs.","breadcrumb":{"@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#primaryimage","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/image-from-rawpixel-id-2288634-jpeg-scaled-1-e1623808424726.jpg","width":2560,"height":1478,"caption":"A scientist holding bacterial samples for their antimicrobial susceptibility. Original image sourced from US Government department: Public Health Image Library, Centers for Disease Control and Prevention. Under US law this image is copyright free, please credit the government department whenever you can”."},{"@type":"BreadcrumbList","@id":"https:\/\/joinastudy.ca\/fr\/glp-1-agonists-making-the-informed-choice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/joinastudy.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Agonists: Making the Informed Choice"}]},{"@type":"WebSite","@id":"https:\/\/joinastudy.ca\/fr\/#website","url":"https:\/\/joinastudy.ca\/fr\/","name":"JoinAStudy.ca","description":"JoinAStudy.ca - Help create a healthier future","publisher":{"@id":"https:\/\/joinastudy.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/joinastudy.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/joinastudy.ca\/fr\/#organization","name":"JoinAStudy.ca","url":"https:\/\/joinastudy.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","contentUrl":"https:\/\/joinastudy.ca\/wp-content\/uploads\/JoinaStudy-Logo-Mobile-e1520526932796.png","width":118,"height":65,"caption":"JoinAStudy.ca"},"image":{"@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/joinastudy.ca","https:\/\/x.com\/JoinAStudy_ca","https:\/\/www.youtube.com\/channel\/UC_ed0XmzH5ImSNOEJcdXKqg"],"publishingPrinciples":"https:\/\/joinastudy.ca\/why-join-a-study\/","ownershipFundingInfo":"https:\/\/joinastudy.ca\/information-disclaimer\/"},{"@type":"Person","@id":"https:\/\/joinastudy.ca\/fr\/#\/schema\/person\/da824a10716e724d72676ec94d865d71","name":"JoinAStudy Team","url":"https:\/\/joinastudy.ca\/fr\/author\/grant\/"}]}},"_links":{"self":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/35576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/users\/964"}],"replies":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/comments?post=35576"}],"version-history":[{"count":5,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/35576\/revisions"}],"predecessor-version":[{"id":35657,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/posts\/35576\/revisions\/35657"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media\/29913"}],"wp:attachment":[{"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/media?parent=35576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/categories?post=35576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/joinastudy.ca\/fr\/wp-json\/wp\/v2\/tags?post=35576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}